tetano
Editor, Senior Moderator
Int Immunopharmacol
. 2022 Aug 8;111:109128.
doi: 10.1016/j.intimp.2022.109128. Online ahead of print.
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad[SUP] 1 [/SUP], Mohammad-Javad Sanaei[SUP] 2 [/SUP], Atieh Pourbagheri-Sigaroodi[SUP] 2 [/SUP], Davood Bashash[SUP] 3 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the outbreak of coronavirus disease 2019 (COVID-19), has shown a vast range of clinical manifestations from asymptomatic to life-threatening symptoms. To figure out the cause of this heterogeneity, studies demonstrated the trace of genetic diversities whether in the hosts or the virus itself. With this regard, this review provides a comprehensive overview of how host genetic such as those related to the entry of the virus, the immune-related genes, gender-related genes, disease-related genes, and also host epigenetic could influence the severity of COVID-19. Besides, the mutations in the genome of SARS-CoV-2 [SUP]__[/SUP]leading to emerging of new variants[SUP]__[/SUP] per se affect the affinity of the virus to the host cells and enhance the immune escape capacity. The current review discusses these variants and also the latest data about vaccination effectiveness facing the most important variants.
Keywords: ACE2; COVID-19; Genetic diversity; Mutation; SARS-CoV-2; Vaccine.
. 2022 Aug 8;111:109128.
doi: 10.1016/j.intimp.2022.109128. Online ahead of print.
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad[SUP] 1 [/SUP], Mohammad-Javad Sanaei[SUP] 2 [/SUP], Atieh Pourbagheri-Sigaroodi[SUP] 2 [/SUP], Davood Bashash[SUP] 3 [/SUP]
Affiliations
- PMID: 35963158
- PMCID: PMC9359488
- DOI: 10.1016/j.intimp.2022.109128
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the outbreak of coronavirus disease 2019 (COVID-19), has shown a vast range of clinical manifestations from asymptomatic to life-threatening symptoms. To figure out the cause of this heterogeneity, studies demonstrated the trace of genetic diversities whether in the hosts or the virus itself. With this regard, this review provides a comprehensive overview of how host genetic such as those related to the entry of the virus, the immune-related genes, gender-related genes, disease-related genes, and also host epigenetic could influence the severity of COVID-19. Besides, the mutations in the genome of SARS-CoV-2 [SUP]__[/SUP]leading to emerging of new variants[SUP]__[/SUP] per se affect the affinity of the virus to the host cells and enhance the immune escape capacity. The current review discusses these variants and also the latest data about vaccination effectiveness facing the most important variants.
Keywords: ACE2; COVID-19; Genetic diversity; Mutation; SARS-CoV-2; Vaccine.